Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1989-4-20
|
pubmed:abstractText |
Recently, the presence of a soluble form of IL-2 receptor (IL-2RS) in human sera and in supernatants of PHA-stimulated lymphocytes has been demonstrated. It has been suggested that autoimmune diseases could be characterized by a defect in production of IL-2RS, unlike immunoproliferative disorders which are characterized by overproduction. Our aim was to investigate serum IL-2RS levels in 35 newly diagnosed Type 1 diabetic patients, in 25 age-matched healthy blood donors and in five patients with Hodgkin's disease. We found that newly diagnosed diabetic patients have higher IL-2RS levels (424.8 +/- 203 U/ml) than normal controls (252.4 +/- 38.4 U/ml) (p less than 0.005). In 22 out of 35 patients (62.8%) the IL-2RS values were above the higher 95% tolerance limit of controls. Furthermore, the persistence of high IL-2RS levels was observed in 18/35 diabetic patients six months after diagnosis (470 +/- 195.6 U/ml). The increased levels were not correlated with glycaemic and HbA1c levels and patients' age. Our findings suggest a potentially significant role for the released IL-2R in the regulation of IL-2 dependent lymphocyte functions in Type 1 diabetes. The study of IL-2RS in Type 1 diabetes may provide a new tool for the knowledge of cytokine involvement in the disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0265-5985
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
135-8
|
pubmed:dateRevised |
2007-9-11
|
pubmed:meshHeading |
pubmed-meshheading:3265901-Adolescent,
pubmed-meshheading:3265901-Adult,
pubmed-meshheading:3265901-Diabetes Mellitus, Type 1,
pubmed-meshheading:3265901-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:3265901-Female,
pubmed-meshheading:3265901-Follow-Up Studies,
pubmed-meshheading:3265901-Hemoglobin A, Glycosylated,
pubmed-meshheading:3265901-Hodgkin Disease,
pubmed-meshheading:3265901-Humans,
pubmed-meshheading:3265901-Male,
pubmed-meshheading:3265901-Receptors, Interleukin-2,
pubmed-meshheading:3265901-Reference Values
|
pubmed:year |
1988
|
pubmed:articleTitle |
Increased soluble interleukin-2 receptor levels in the sera of type 1 diabetic patients.
|
pubmed:affiliation |
Clinica Medica T, University of Palermo, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|